陆嘉惠中西医结合治疗原发免疫性血小板减少症的决策思路  

Decision⁃making strategies of Lu Jiahui in treating primary immune thrombocytopenia with integrated traditional Chinese and western medicine

作　　者：陶雨晨 陆嘉惠[1] 邓剑青[1] 胡琦[1] 鲍计章[1] 任建业 王冬琴[1] TAO Yuchen;LU Jiahui;DENG Jianqing;HU Qi;BAO Jizhang;REN Jianye;WANG Dongqin(Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200071,China)

机构地区：[1]上海中医药大学附属市中医医院,上海200071

出　　处：《上海中医药杂志》2022年第11期38-42,共5页Shanghai Journal of Traditional Chinese Medicine

基　　金：上海市科委优秀学术带头人计划项目(20XD1403500);上海市卫健委卫生系统优秀人才培养计划项目(2018BR15)。

摘　　要：对原发免疫性血小板减少症(ITP)治疗现状进行梳理,并根据临床实际,找寻ITP中医药治疗切入点,提出ITP中西医结合治疗的决策思路,认为应在现代医学对ITP规范化治疗基础上,加上中医药精准的辨证论治,扬长避短,优势互补。并附验案2则。This paper sorts out the current treatment situation of primary immune thrombocytopenia(ITP),and according to the clinical reality,looks for the breakthrough point of ITP treatment in traditional Chinese medicine,and puts forward the decision-making ideas of ITP treatment in the integrative traditional Chinese and western medicine.Based on the standardized treatment of ITP in western medicine,combined with the accurate treatment based on syndrome differentiation of traditional Chinese medicine,the advantages are fostering strengths and avoiding weaknesses,even complementary.And two proven cases are presented.

关 键 词：原发免疫性血小板减少症 特发性血小板减少性紫癜 中西医结合治疗 辨证论治 临床经验 

分 类 号：R558.2[医药卫生—血液循环系统疾病]